In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.

Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...

Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 decades. With more than 20 FDA-approved therapies now available, clinicians ...

For people living with multiple sclerosis, everyday tasks can become unexpectedly difficult — and finding someone who ...

March is National Multiple Sclerosis Month, a time to raise awareness about the neurological disease that affects more than ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study finds that in about one in 10 cases of multiple sclerosis, the body makes a distinct set of antibodies years before ...

Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the ...

An analysis of data from phase 3 randomized controlled trials showed that among individuals with comparable disease duration, inflammatory disease activity was significantly lower in older trial ...

Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS).

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a new study aims to challenge that approach, presenting evidence that MS may ...

Multiple sclerosis prevalence has increased by 6% annually, reaching an estimated 190,000 cases today. New research ...

Project MS Shift aims to raise awareness and access to Delawareans — especially Black Delawareans — who are impacted by ...